|
1. Xiaoyi Zhang#, Lin Gui#, Xiaoyan Zhang, Stacie L. Bulfer, Valentina Sanghez, Daniel Wong, James Siho Lee, Pei-Yin Shih, Conrad C. Weihl, Henry J. Lin, Michelina Iacovino, Michelle R. Arkin, Yanzhuang Wang, and Tsui-Fen Chou Altered cofactor regulation of p97/VCP ATPase mutants in IBMPFD/ALS Proceedings of the National Academy of Sciences,2015, E1705–E1714 .(#Co-author) IF= 9.674
2. Chen-Jie Fang#, Lin Gui#, Xiaoyi Zhang#, Derek R. Moen, Kelin Li, Kevin J. Frankowski, Henry J. Lin, Frank J. Schoenen, and Tsui-Fen Chou Evaluating p97 Inhibitor Analogues for Their Domain Selectivity and Potency against the p97–p47 Complex. ChemMedChem, 2015, 10(1): 52-56. (#Co-author) IF= 2.9683
3. Xiaoyi Zhang, Yifan Yang, Ming Zhao, Liu Liu, Meiqing Zheng, Yuji Wang, Jianhui Wu, Shiqi Pen. A class of Trp-Trp-AA-OBzl: Synthesis, in vitro anti-proliferation/in vivo anti-tumor evaluation, intercalation-mechanism investigation and 3D QSAR analysis. European Journal of Medicinal Chemistry, 2011, 46, 3410-3419. IF=3.346
4. Xiaoyi Zhang, Wei Wang, Shenling Cheng, Ming Zhao,Meiqing Zheng, Heng Wei Chang, Jianhui Wu, Shiqi Peng. 2,3-Diamino acid modifying 3S-tetrahydroisoquinoline-3- carboxylic acids:Leading to a class of novel agents with highly unfolded conformation, selective in vitro anti-platelet aggregation and potent in vivo anti-thrombotic activity. Bioorganic Medicinal Chemistry, 2010, 18, 1536–1554. IF = 2.793
|
|